Davari Nima, Khashei Reza, Pourabbas Bahman, Nikbin Vajihe Sadat, Zand Farid
Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Iran J Basic Med Sci. 2022 Dec;25(12):1416-1423. doi: 10.22038/IJBMS.2022.63099.13938.
The worldwide emergence of carbapenem-resistant Enterobacteriaceae (CRE) has become a major therapeutic concern to medical institutions. To date, no study has determined the frequency and risk factors of inpatients with CRE fecal carriage in Southern Iran. We studied the features of carbapenemase-producing Enterobacteriaceae (CPE) collected from the central ICU of a university hospital.
Totally, 173 samples, including 124 stool samples from 46 ICU inpatients on admission and different follow-ups, 9 ICU staff, and 40 environmental samples were included. CRE was identified using microbiological methods. Antimicrobial susceptibility was investigated by using the disk diffusion method and E-test. Carbapenemase producers were detected using the mCIM method. Seven carbapenemase genes were characterized. The genetic relationship among 20 CPE was elucidated by PFGE.
The overall fecal carriage rate was 28.2%, while CRE acquisition was 6.1%. CRE were classified as (71.4%), (23.8%), and (4.8%). From 21 CRE, 20 (95.2%) produced carbapenemases, of which 10, 15, 10, 25, 5, and 65% were , , , , and 48-positive, respectively. Out of 20 CPE, 14 different PFGE patterns were observed, categorized into six clusters, suggestive of non-clonal spread. No difference between the examined risk factors with CRE carriage was shown.
The data indicate a high CRE fecal carriage rate among inpatients. Our findings implicate the widespread of OXA-48 carbapenemase together with heterogeneity among CRE with great concern for dissemination and therapeutic threat. Early diagnosis and monitoring of CRE among inpatients are urgent.
耐碳青霉烯类肠杆菌科细菌(CRE)在全球范围内的出现已成为医疗机构主要的治疗关注点。迄今为止,尚无研究确定伊朗南部住院患者CRE粪便携带的频率和危险因素。我们研究了从一所大学医院中心重症监护病房收集的产碳青霉烯酶肠杆菌科细菌(CPE)的特征。
共纳入173份样本,包括46名重症监护病房住院患者入院时及不同随访阶段的124份粪便样本、9名重症监护病房工作人员的样本以及40份环境样本。采用微生物学方法鉴定CRE。使用纸片扩散法和E-test法研究抗菌药物敏感性。采用改良碳青霉烯灭活试验(mCIM)检测碳青霉烯酶产生菌。对7种碳青霉烯酶基因进行了特征分析。通过脉冲场凝胶电泳(PFGE)阐明了20株CPE之间的遗传关系。
总体粪便携带率为28.2%,而CRE获得率为6.1%。CRE分为(71.4%)、(23.8%)和(4.8%)。在21株CRE中,20株(95.2%)产生碳青霉烯酶,其中分别有10%、15%、10%、25%、5%和ó5%为、、、、阳性,48株为阳性。在20株CPE中,观察到14种不同的PFGE模式,分为6个簇,提示非克隆传播。所检查的危险因素与CRE携带之间未显示出差异。
数据表明住院患者中CRE粪便携带率较高。我们的研究结果表明OXA-48碳青霉烯酶广泛存在,且CRE之间存在异质性,这对传播和治疗构成了极大的威胁。对住院患者进行CRE的早期诊断和监测迫在眉睫。